Download PDF
Arzneimittelforschung 2012; 62(05): 209-212
DOI: 10.1055/s-0031-1301293
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

A Simple and Sensitive HPLC-UV Method for the Determination of Swainsonine in Rat Plasma and its Application in a Pharmacokinetic Study

D.-L. Li
1   Department of Hepatobiliary, Fuzhou General Hospital, Fuzhou, China
,
C.-Y. Dong
2   Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai, China
,
Y. Gao
2   Department of Oncology, Shanghai East Hospital, Tongji University, Shanghai, China
› Author Affiliations
Further Information

Publication History

received 02 December 2011

accepted 22 December 2011

Publication Date:
27 January 2012 (online)

    Permissions and Reprints

Abstract

A simple, rapid, selective and sensitive HPLC-UV method was developed and validated for the determination of swainsonine (SWSN) in rat plasma. The analyte was extracted from rat plasma with methanol as the extraction solvent. The LC separation was performed on a Diamonsil® C18 (250×4.6 mm, 5 µm) analytical column with a mobile phase consisting of acetonitrile-potassium dihydrogen phosphate (25 mmol/l, pH=7.5) at a flow rate of 1.0 ml/min. There was a good linearity over the range of 10–500 ng/ml (r=0.9995) with a weighted (1/C2) least square method. The lower limit of quantification was proved to be 10 ng/ml. The accuracy was within 4.8% in terms of relative error and the intra- and inter-day precisions were less than 9.0% in terms of relative standard deviation. After validation, the method was successfully applied to characterize the pharmacokinetics of SWSN in rats.

Key words

swainsonine - HPLC - method validation - pharmacokinetics
 

  • References

  • 1 Dorling PR, Huxtable CR, Colegate SM. Inhibition of lysosomal a-mannosidase by SWSN, an indolizidine alkaloid isolated from Swainsona canescens. Biochem J 1980; 191: 649-651
    PubMedSearch in Google Scholar
  • 2 Dorling PR, Colegate SM, Huxtable CR. Toxic species of the plant genus Swainsona. In: Swainsonine and Related Glycosidase Inhibitors. James LF, Elbein AD, Molyneux RJ, Warren CD. eds. Iowa State University Press; 1989. Ames, IA: 14-22
    Search in Google Scholar
  • 3 Sun JY, Yang H, Miao S et al. Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo. Phytomedicine 2009; 16 (11) 1070-1074
    CrossrefPubMedSearch in Google Scholar
  • 4 Rooprai HK, Kandanearatchi A, Maidment SL et al. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol 2001; 27 (01) 29-39
    CrossrefPubMedSearch in Google Scholar
  • 5 Sun JY, Zhu MZ, Wang SW et al. Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine. Phytomedicine 2007; 14 (05) 353-359
    CrossrefPubMedSearch in Google Scholar
  • 6 Hamaguchi J, Nakagawa H, Takahashi M et al. Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines. Mol Cancer 2007; 6: 58
    CrossrefPubMedSearch in Google Scholar
  • 7 Molyneux RJ, James LF, Panter KE et al. Analysis and distribution of swainsonine and related polyhydroxyindolizidine alkaloids by thin layer chromatography. Phytochem Anal 1991; 2: 125-129
    CrossrefPubMedSearch in Google Scholar
  • 8 Gardner DR, Molyneux RJ, Ralphs MH. Analysis of swainsonine: extraction methods, detection, and measurement in population of locoweeds (Oxytropis spp.). J Agric Food Chem 2001; 49: 4573-4580
    CrossrefPubMedSearch in Google Scholar
  • 9 Gardner DR, Cook D. A comparison of alternative sample preparation procedures for the analysis of swainsonine using LC-MS/MS. Phytochem Anal 2011; 22 (02) 124-127
    CrossrefPubMedSearch in Google Scholar